Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors

BACKGROUND: Carmustine (BCNU) wafers (Gliadel) prolongs local disease control and progression-free survival (PFS) in patients with malignant gliomas. However, in metastatic brain tumors, there is a paucity of evidence in support of its safety and efficacy. The goal of this study was to assess the sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ene, Chibawanye I., Nerva, John D., Morton, Ryan P., Barkley, Ariana S., Barber, Jason K., Ko, Andrew L., Silbergeld, Daniel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Surgical Neurology International: Neuro-Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866053/
https://www.ncbi.nlm.nih.gov/pubmed/27217968
http://dx.doi.org/10.4103/2152-7806.181987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866053/
https://www.ncbi.nlm.nih.gov/pubmed/27217968
http://dx.doi.org/10.4103/2152-7806.181987

Ejemplares similares